Abstract: The era of the genome promised that human genetics would quickly translate into personalized medicine. Genome-wide association studies on large samples from human populations have indicated that main effects of common polymorphisms or rare variants are unlikely to lead to improved ability to predict disease risk and therapeutic response. Epistasis (gene-gene interaction) and pleiotropy (diverse effects of the same gene) are known to play major roles in the genetic architecture of complex traits in model organisms, but have not yet been explored in human biology. This project aims to overcome the current challenge in human genetics in an innovative way by studying autism traits in congenital disorders of the Ras-MAPK pathway. Autism is a complex heritable disorder affecting nearly 1% of the population, and like most complex genetic disorders, the heritability is unaccounted for by current models of genetic association. Ras-MAPK diseases are genetic disorders with known mutations that include effects on craniofacial, cardiac, cutaneous, musculoskeletal and ocular development, as well as carrying increased risk of cancer and varying expression of neurocognitive impairment. Our preliminary data shows that these disorders are strongly associated with autism and that common polymorphisms in the same genes are associated with idiopathic familial autism. Therefore, Ras-MAPK pathway disorders provide an ideal model by which to explore epistasis and pleiotropy in the complex trait of autism. We will ascertain subjects with Ras-MAPK disorders, measure autism-related traits, and perform genome-wide mapping for interactors with the known Ras-MAPK genes. We will then establish induced pluripotent stem cell models from fibroblasts of patients with these disorders in order to investigate expression and functional assays utilizing cells differentiated into varying fates. This project has great translational potential not only for understanding how genetic variants mediate disease risk, but also with immediate implications for treatment approaches. Public Health Relevance: Autism Spectrum Disorders have recently been estimated to affect nearly 1% of Americans, and can cause severe disability to individuals and families across the lifespan with extremely limited treatment options. With better understanding of the genetic architecture of autism and causes of common co-morbidities, diagnosis, prognosis, prevention and treatment options could be improved. This project could lead the way to translating genetics into medicine for other common complex genetic disorders.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
NIH Director’s New Innovator Awards (DP2)
Project #
3DP2OD007449-01S1
Application #
8803025
Study Section
Program Officer
Basavappa, Ravi
Project Start
2010-09-30
Project End
2015-06-30
Budget Start
2010-09-30
Budget End
2015-06-30
Support Year
1
Fiscal Year
2014
Total Cost
$83,334
Indirect Cost
$30,591
Name
University of California San Francisco
Department
Psychiatry
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Young, Olivia; Perati, Shriya; Weiss, Lauren A et al. (2018) Age and ASD symptoms in Costello syndrome. Am J Med Genet A 176:1027-1028
Yeh, E; Dao, D Q; Wu, Z Y et al. (2018) Patient-derived iPSCs show premature neural differentiation and neuron type-specific phenotypes relevant to neurodevelopment. Mol Psychiatry 23:1687-1698
Bizaoui, Varoona; Gage, Jessica; Brar, Rita et al. (2018) RASopathies are associated with a distinct personality profile. Am J Med Genet B Neuropsychiatr Genet 177:434-446
Deshpande, Aditi; Yadav, Smita; Dao, Dang Q et al. (2017) Cellular Phenotypes in Human iPSC-Derived Neurons from a Genetic Model of Autism Spectrum Disorder. Cell Rep 21:2678-2687
Josowitz, Rebecca; Mulero-Navarro, Sonia; Rodriguez, Nelson A et al. (2016) Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes. Stem Cell Reports 7:355-369
Rooney, Gemma E; Goodwin, Alice F; Depeille, Philippe et al. (2016) Human iPS Cell-Derived Neurons Uncover the Impact of Increased Ras Signaling in Costello Syndrome. J Neurosci 36:142-52
Morris, Stephanie M; Acosta, Maria T; Garg, Shruti et al. (2016) Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT). JAMA Psychiatry 73:1276-1284
Krencik, Robert; Hokanson, Kenton C; Narayan, Aditi R et al. (2015) Dysregulation of astrocyte extracellular signaling in Costello syndrome. Sci Transl Med 7:286ra66
Adviento, Brigid; Corbin, Iris L; Widjaja, Felicia et al. (2014) Autism traits in the RASopathies. J Med Genet 51:10-20
Goodwin, A F; Oberoi, S; Landan, M et al. (2013) Craniofacial and dental development in cardio-facio-cutaneous syndrome: the importance of Ras signaling homeostasis. Clin Genet 83:539-44